Association between control group therapy and magnitude of clinical benefit of cancer drugs - Molto, Consolacion (Princess Margaret Cancer Centre and University of Toronto. Division of Medical Oncology and Hematology, Department of Medicine) ; Tibau Martorell, Ariadna (Institut d'Investigació Biomèdica Sant Pau) ; Bujosa, Aida (Hospital Universitari Son Llàtzer (Palma de Mallorca, Balears)) ; Tapia, Jose Carlos (Institut d'Investigació Biomèdica Sant Pau) ; Mittal, Abhenil (Princess Margaret Cancer Centre and University of Toronto. Division of Medical Oncology and Hematology, Department of Medicine) ; Tamimi, Faris (Princess Margaret Cancer Centre and University of Toronto. Division of Medical Oncology and Hematology, Department of Medicine) ; Amir, Eitan (Princess Margaret Cancer Centre and University of Toronto. Division of Medical Oncology and Hematology, Department of Medicine) ; Universitat Autònoma de Barcelona
 
Comments (0) | Reviews (0)
Start a discussion about any aspect of this document.

 Subscribe to this discussion. You will then receive all new comments by email.

Add comment


Once logged in, authorized users can also attach files.
Note: you have not defined your nickname.
N/D will be displayed as the author of this comment.
          You can use some HTML tags: <a href>, <strong>, <blockquote>, <br />, <p>, <em>, <ul>, <li>, <b>, <i>